By downregulating GPX4 for ferroptosis induction, miR-324-3p attenuates cisplatin resistance in lung cancer cells [231], and miR-450b-5p suppresses sorafenib resistance in liver cancer cells [232]. Here, GPX4 is linked to lung carcinoma.